1. Home
  2. SLDB vs DOYU Comparison

SLDB vs DOYU Comparison

Compare SLDB & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • DOYU
  • Stock Information
  • Founded
  • SLDB 2013
  • DOYU 2014
  • Country
  • SLDB United States
  • DOYU China
  • Employees
  • SLDB N/A
  • DOYU N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • DOYU Computer Software: Programming Data Processing
  • Sector
  • SLDB Health Care
  • DOYU Technology
  • Exchange
  • SLDB Nasdaq
  • DOYU Nasdaq
  • Market Cap
  • SLDB 234.8M
  • DOYU 195.9M
  • IPO Year
  • SLDB 2018
  • DOYU 2019
  • Fundamental
  • Price
  • SLDB $4.60
  • DOYU $6.43
  • Analyst Decision
  • SLDB Strong Buy
  • DOYU Hold
  • Analyst Count
  • SLDB 10
  • DOYU 2
  • Target Price
  • SLDB $15.10
  • DOYU $11.00
  • AVG Volume (30 Days)
  • SLDB 2.0M
  • DOYU 40.8K
  • Earning Date
  • SLDB 08-12-2025
  • DOYU 05-20-2025
  • Dividend Yield
  • SLDB N/A
  • DOYU 303.88%
  • EPS Growth
  • SLDB N/A
  • DOYU N/A
  • EPS
  • SLDB N/A
  • DOYU N/A
  • Revenue
  • SLDB N/A
  • DOYU $575,786,186.00
  • Revenue This Year
  • SLDB N/A
  • DOYU N/A
  • Revenue Next Year
  • SLDB N/A
  • DOYU N/A
  • P/E Ratio
  • SLDB N/A
  • DOYU N/A
  • Revenue Growth
  • SLDB N/A
  • DOYU N/A
  • 52 Week Low
  • SLDB $2.41
  • DOYU $5.68
  • 52 Week High
  • SLDB $10.37
  • DOYU $20.17
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 55.67
  • DOYU 43.78
  • Support Level
  • SLDB $4.49
  • DOYU $6.35
  • Resistance Level
  • SLDB $5.16
  • DOYU $6.58
  • Average True Range (ATR)
  • SLDB 0.43
  • DOYU 0.20
  • MACD
  • SLDB -0.04
  • DOYU 0.01
  • Stochastic Oscillator
  • SLDB 27.37
  • DOYU 47.62

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About DOYU DouYu International Holdings Limited ADS

DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.

Share on Social Networks: